Search Results 161-170 of 15435 for Phosphate de Potassium

  1. ... DEL/DUP,784,#N/A,#N/A 300000767,HC ALPHA GLOBIN GENE SEQUENCE,868,#N/A,921.00 300000768,HC HBA1/HBA2 ALPHA GLOBIN GENE SEQ,867,#N/A,920.00 300000783,HC JAK2 ...

  2. Medical Research & Education - Mayo Clinic News Network

    Lynda De Widt. November 26, 2022. First · Previous ... 70 · 71 · 72 · 73 · 74 · 75 · 76 ... Next · Last · Sign up to receive email notifications. Explore more ...

  3. Drugs and Supplements that Start with F - Mayo Clinic

    Sodium phosphate dibasic and sodium phosphate monobasic (oral route). Fleet Sof-Lax. Also known as. Docusate sodium (oral route). Fleqsuvy. Also known as.

  4. Cardiovascular Medicine - Clinical trials

    ... potassium voltage-gated channel subfamily Q member 1 (KCNQ1), potassium voltage-gated channel subfamily H member 2 (KCNH2), or sodium voltage-gated ...

  5. Cardiovascular Medicine - Clinical trials

    ... potassium voltage-gated channel subfamily Q member 1 (KCNQ1), potassium voltage-gated channel subfamily H member 2 (KCNH2), or sodium voltage-gated ...

  6. Cardiovascular Medicine - Clinical trials

    ... potassium voltage-gated channel subfamily Q member 1 (KCNQ1), potassium voltage-gated channel subfamily H member 2 (KCNH2), or sodium voltage-gated ...

  7. Cardiovascular Medicine - Clinical trials

    ... potassium voltage-gated channel subfamily Q member 1 (KCNQ1), potassium voltage-gated channel subfamily H member 2 (KCNH2), or sodium voltage-gated ...

  8. Pulmonary Medicine - Clinical trials

    The purpose of this study is toexamine whether increased sphingosine 1 phosphate : ceramide ratio and circulating bile acids are associated with HPS in patients ...

  9. Cardiovascular Medicine - Clinical trials

    ... potassium voltage-gated channel subfamily Q member 1 (KCNQ1), potassium voltage-gated channel subfamily H member 2 (KCNH2), or sodium voltage-gated ...

  10. Randomized Phase II/III Trial of Adjuvant Radiation Therapy with Cisplatin, Docetaxel-Cetuximab, or Cisplatin-Atezolizumab in Pathologic High-Risk Squamous Cell Cancer of the Head and Neck - Mayo Clinic

    The following assessments are required within 14 days prior to registration: sodium (Na), potassium (K), chloride (Cl), glucose, calcium (Ca), magnesium (Mg) ...